Medipost Co. Ltd. | Mutual Funds
Mutual Funds that own Medipost Co. Ltd.
Vanguard Total International Stock Index Fund
103,323
1.31%
0
0%
07/31/2018
iShares Core MSCI Emerging Markets ETF
77,592
0.99%
0
0.02%
09/05/2018
47,101
0.6%
0
1.1%
09/06/2018
Vanguard Developed Markets Index Fund
40,122
0.51%
0
0%
07/31/2018
Vanguard FTSE All World (ex-US) Small Cap
17,354
0.22%
0
0.02%
07/31/2018
Mirae Asset TIGER Health Care ETF
15,185
0.19%
4,381
0.94%
04/30/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
13,922
0.18%
0
0.01%
09/05/2018
Vanguard Pacific Stock Index Fund
7,412
0.09%
0
0.01%
07/31/2018
Government Pension Fund - Global (The)
6,633
0.08%
-41,272
0%
12/31/2017
Schwab International Small Cap Equity ETF
6,594
0.08%
0
0.03%
09/06/2018
| Address |
21 Daewangpangyo-ro 644 beon-gil
Seongnam GY 13494
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.medi-post.co.kr |
| Updated |
09/14/2018 |
| Medipost Co., Ltd. engages in the development and manufacture of stem cell biotechnology products. It operates through the following business divisions: Cord Blood Bank, Stem Cell Therapy, Health Functional Food, Import and Distribution of Natural Cosmetics and Healthcare Services. The Cord Blood Bank division is involved in collecting and storing stem cells from the newborn's umbilical cord. |
